MRK logo

Merck & Co (MRK) Cash from financing

annual CFF:

-$7.03B-$2.22B(-46.20%)
December 31, 2024

Summary

  • As of today (May 31, 2025), MRK annual cash flow from financing activities is -$7.03 billion, with the most recent change of -$2.22 billion (-46.20%) on December 31, 2024.
  • During the last 3 years, MRK annual CFF has fallen by -$9.63 billion (-371.19%).
  • MRK annual CFF is now -371.19% below its all-time high of $2.59 billion, reached on December 31, 2021.

Performance

MRK Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRKcash flow metrics

quarterly CFF:

-$5.75B-$2.75B(-91.26%)
March 1, 2025

Summary

  • As of today (May 31, 2025), MRK quarterly cash flow from financing activities is -$5.75 billion, with the most recent change of -$2.75 billion (-91.26%) on March 1, 2025.
  • Over the past year, MRK quarterly CFF has dropped by -$2.94 billion (-104.51%).
  • MRK quarterly CFF is now -210.52% below its all-time high of $5.21 billion, reached on December 31, 2021.

Performance

MRK quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRKcash flow metrics

TTM CFF:

-$9.97B-$2.94B(-41.82%)
March 1, 2025

Summary

  • As of today (May 31, 2025), MRK TTM cash flow from financing activities is -$9.97 billion, with the most recent change of -$2.94 billion (-41.82%) on March 1, 2025.
  • Over the past year, MRK TTM CFF has dropped by -$4.40 billion (-79.05%).
  • MRK TTM CFF is now -484.61% below its all-time high of $2.59 billion, reached on December 31, 2021.

Performance

MRK TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRKcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

MRK Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-46.2%-104.5%-79.0%
3 y3 years-371.2%-86.5%-721.4%
5 y5 years+20.6%-286.2%-14.2%

MRK Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-371.2%+22.9%-253.1%at low-721.4%at low
5 y5-year-371.2%+22.9%-210.5%at low-484.6%at low
alltimeall time-371.2%+53.9%-210.5%+41.1%-484.6%+34.6%

MRK Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$5.75B(+91.3%)
-$9.97B(+41.8%)
Dec 2024
-$7.03B(+46.2%)
-$3.01B(+24.1%)
-$7.03B(+12.2%)
Sep 2024
-
-$2.42B(-299.4%)
-$6.27B(-22.7%)
Jun 2024
-
$1.22B(-143.2%)
-$8.11B(+45.6%)
Mar 2024
-
-$2.81B(+25.3%)
-$5.57B(+15.8%)
Dec 2023
-$4.81B(-47.3%)
-$2.25B(-47.4%)
-$4.81B(+16.8%)
Sep 2023
-
-$4.27B(-213.6%)
-$4.12B(+61.4%)
Jun 2023
-
$3.76B(-283.0%)
-$2.55B(-68.4%)
Mar 2023
-
-$2.05B(+32.2%)
-$8.09B(-11.3%)
Dec 2022
-$9.12B(-451.7%)
-$1.55B(-42.5%)
-$9.12B(+286.7%)
Sep 2022
-
-$2.70B(+52.1%)
-$2.36B(+22.2%)
Jun 2022
-
-$1.78B(-42.4%)
-$1.93B(-220.2%)
Mar 2022
-
-$3.09B(-159.3%)
$1.60B(-38.1%)
Dec 2021
$2.59B(-191.6%)
$5.21B(-329.0%)
$2.59B(-308.8%)
Sep 2021
-
-$2.27B(-229.4%)
-$1.24B(-55.9%)
Jun 2021
-
$1.76B(-183.8%)
-$2.82B(-18.1%)
Mar 2021
-
-$2.10B(-252.9%)
-$3.44B(+21.5%)
Dec 2020
-$2.83B(-68.0%)
$1.37B(-135.6%)
-$2.83B(-54.4%)
Sep 2020
-
-$3.85B(-438.7%)
-$6.21B(+12.7%)
Jun 2020
-
$1.14B(-176.3%)
-$5.52B(-36.9%)
Mar 2020
-
-$1.49B(-25.9%)
-$8.74B(-1.4%)
Dec 2019
-$8.86B(-32.7%)
-$2.01B(-36.2%)
-$8.86B(-28.6%)
Sep 2019
-
-$3.15B(+51.2%)
-$12.42B(+11.2%)
Jun 2019
-
-$2.08B(+29.1%)
-$11.17B(-7.3%)
Mar 2019
-
-$1.61B(-71.0%)
-$12.05B(-8.4%)
Dec 2018
-$13.16B(+31.5%)
-$5.57B(+192.2%)
-$13.16B(-1.6%)
Sep 2018
-
-$1.91B(-35.8%)
-$13.38B(+22.3%)
Jun 2018
-
-$2.97B(+9.0%)
-$10.94B(-22.9%)
Mar 2018
-
-$2.72B(-52.9%)
-$14.19B(+41.8%)
Dec 2017
-$10.01B(+10.6%)
-$5.79B(-1179.3%)
-$10.01B(+61.4%)
Sep 2017
-
$536.00M(-108.6%)
-$6.20B(-18.1%)
Jun 2017
-
-$6.22B(-525.6%)
-$7.57B(+60.5%)
Mar 2017
-
$1.46B(-173.9%)
-$4.72B(-47.8%)
Dec 2016
-$9.04B(+67.9%)
-$1.98B(+136.8%)
-$9.04B(-4.5%)
Sep 2016
-
-$835.00M(-75.2%)
-$9.47B(-15.2%)
Jun 2016
-
-$3.37B(+17.4%)
-$11.18B(-16.6%)
Mar 2016
-
-$2.87B(+19.1%)
-$13.41B(+148.9%)
Dec 2015
-$5.39B(-64.7%)
-$2.41B(-5.2%)
-$5.39B(-57.8%)
Sep 2015
-
-$2.54B(-54.6%)
-$12.75B(+42.7%)
Jun 2015
-
-$5.60B(-208.6%)
-$8.94B(-23.7%)
Mar 2015
-
$5.16B(-152.8%)
-$11.71B(-23.2%)
Dec 2014
-$15.24B(+154.5%)
-$9.77B(-864.0%)
-$15.24B(+88.3%)
Sep 2014
-
$1.28B(-115.3%)
-$8.09B(-34.1%)
Jun 2014
-
-$8.37B(-616.6%)
-$12.29B(+316.7%)
Mar 2014
-
$1.62B(-161.7%)
-$2.95B(-50.8%)
Dec 2013
-$5.99B(+83.3%)
-$2.62B(-10.0%)
-$5.99B(+30.7%)
Sep 2013
-
-$2.92B(-400.5%)
-$4.58B(+90.4%)
Jun 2013
-
$970.00M(-168.3%)
-$2.41B(-39.3%)
Mar 2013
-
-$1.42B(+16.7%)
-$3.96B(+21.3%)
Dec 2012
-$3.27B(-52.7%)
-$1.22B(+65.0%)
-$3.27B(-23.7%)
Sep 2012
-
-$738.00M(+25.9%)
-$4.28B(-26.0%)
Jun 2012
-
-$586.00M(-19.2%)
-$5.79B(-10.4%)
Mar 2012
-
-$725.00M(-67.5%)
-$6.46B(-6.5%)
Dec 2011
-$6.90B(+26.9%)
-$2.23B(-0.6%)
-$6.90B(+15.7%)
Sep 2011
-
-$2.24B(+78.5%)
-$5.97B(+11.6%)
Jun 2011
-
-$1.26B(+7.3%)
-$5.35B(-29.2%)
Mar 2011
-
-$1.17B(-9.5%)
-$7.55B(+38.9%)
Dec 2010
-$5.44B(+232.2%)
-$1.29B(-20.3%)
-$5.44B(-9.2%)
Sep 2010
-
-$1.63B(-53.1%)
-$6.00B(-11.1%)
Jun 2010
-
-$3.46B(-467.6%)
-$6.74B(+2117.2%)
Mar 2010
-
$942.00M(-150.9%)
-$304.10M(-81.4%)
Dec 2009
-$1.64B(-70.3%)
-$1.85B(-22.1%)
-$1.64B(+6.0%)
Sep 2009
-
-$2.37B(-179.7%)
-$1.54B(-265.7%)
Jun 2009
-
$2.98B(-859.2%)
$932.20M(-140.0%)
Mar 2009
-
-$391.90M(-77.7%)
-$2.33B(-57.8%)
Dec 2008
-$5.52B(+13.5%)
-$1.76B(-1778.7%)
-$5.52B(+7.0%)
Sep 2008
-
$104.60M(-136.3%)
-$5.16B(-21.0%)
Jun 2008
-
-$288.10M(-92.0%)
-$6.53B(-9.7%)
Mar 2008
-
-$3.58B(+156.9%)
-$7.23B(+48.6%)
Dec 2007
-$4.87B
-$1.40B(+10.3%)
-$4.87B(+25.0%)
Sep 2007
-
-$1.26B(+27.7%)
-$3.89B(-5.8%)
DateAnnualQuarterlyTTM
Jun 2007
-
-$990.20M(-18.6%)
-$4.13B(-10.2%)
Mar 2007
-
-$1.22B(+189.3%)
-$4.60B(-17.9%)
Dec 2006
-$5.60B(+84.3%)
-$420.40M(-72.0%)
-$5.60B(+1.3%)
Sep 2006
-
-$1.50B(+3.1%)
-$5.53B(+10.7%)
Jun 2006
-
-$1.46B(-34.3%)
-$5.00B(+6.3%)
Mar 2006
-
-$2.22B(+534.8%)
-$4.70B(+54.6%)
Dec 2005
-$3.04B(-45.6%)
-$350.00M(-63.8%)
-$3.04B(-40.1%)
Sep 2005
-
-$966.80M(-16.8%)
-$5.08B(-1.5%)
Jun 2005
-
-$1.16B(+106.9%)
-$5.15B(-2.2%)
Mar 2005
-
-$561.70M(-76.5%)
-$5.27B(-5.7%)
Dec 2004
-$5.59B(-18.1%)
-$2.39B(+129.3%)
-$5.59B(-25.8%)
Sep 2004
-
-$1.04B(-18.5%)
-$7.53B(-10.0%)
Jun 2004
-
-$1.28B(+44.7%)
-$8.37B(+5.2%)
Mar 2004
-
-$883.20M(-79.6%)
-$7.95B(+16.5%)
Dec 2003
-$6.83B(+23.4%)
-$4.33B(+130.6%)
-$6.83B(+45.1%)
Sep 2003
-
-$1.88B(+117.4%)
-$4.71B(+11.5%)
Jun 2003
-
-$863.40M(-457.4%)
-$4.22B(-18.5%)
Mar 2003
-
$241.60M(-111.0%)
-$5.18B(-6.4%)
Dec 2002
-$5.53B(+16.5%)
-$2.21B(+58.5%)
-$5.53B(+17.7%)
Sep 2002
-
-$1.39B(-23.6%)
-$4.70B(-14.5%)
Jun 2002
-
-$1.82B(+1513.0%)
-$5.49B(+55.6%)
Mar 2002
-
-$112.90M(-91.8%)
-$3.53B(-25.7%)
Dec 2001
-$4.75B(+37.8%)
-$1.37B(-37.2%)
-$4.75B(+28.0%)
Sep 2001
-
-$2.19B(-1633.1%)
-$3.71B(+11.9%)
Jun 2001
-
$142.70M(-110.7%)
-$3.31B(-0.0%)
Mar 2001
-
-$1.33B(+299.1%)
-$3.32B(-3.8%)
Dec 2000
-$3.45B(-10.9%)
-$333.80M(-81.4%)
-$3.45B(-3.9%)
Sep 2000
-
-$1.79B(-1368.9%)
-$3.59B(+44.5%)
Jun 2000
-
$141.20M(-109.7%)
-$2.48B(-44.4%)
Mar 2000
-
-$1.46B(+209.1%)
-$4.46B(+15.4%)
Dec 1999
-$3.87B(-1.3%)
-$473.40M(-31.0%)
-$3.87B(-14.9%)
Sep 1999
-
-$686.50M(-62.7%)
-$4.55B(-19.2%)
Jun 1999
-
-$1.84B(+112.3%)
-$5.63B(+30.4%)
Mar 1999
-
-$867.50M(-24.8%)
-$4.31B(+10.0%)
Dec 1998
-$3.92B(-19.3%)
-$1.15B(-34.6%)
-$3.92B(-9.7%)
Sep 1998
-
-$1.76B(+233.7%)
-$4.34B(-9.4%)
Jun 1998
-
-$528.80M(+11.6%)
-$4.79B(+3.1%)
Mar 1998
-
-$473.90M(-69.9%)
-$4.65B(-4.4%)
Dec 1997
-$4.86B(+26.6%)
-$1.57B(-29.0%)
-$4.86B(+13.5%)
Sep 1997
-
-$2.22B(+474.8%)
-$4.28B(+61.8%)
Jun 1997
-
-$385.40M(-43.8%)
-$2.65B(-31.4%)
Mar 1997
-
-$685.80M(-31.1%)
-$3.86B(+0.5%)
Dec 1996
-$3.84B(+173.8%)
-$994.80M(+71.6%)
-$3.84B(+50.3%)
Sep 1996
-
-$579.80M(-63.7%)
-$2.55B(+16.0%)
Jun 1996
-
-$1.60B(+140.1%)
-$2.20B(+85.1%)
Mar 1996
-
-$665.40M(-329.8%)
-$1.19B(-15.2%)
Dec 1995
-$1.40B(-58.8%)
$289.60M(-227.3%)
-$1.40B(-57.1%)
Sep 1995
-
-$227.50M(-61.1%)
-$3.27B(-15.8%)
Jun 1995
-
-$585.50M(-33.3%)
-$3.88B(+6.9%)
Mar 1995
-
-$878.00M(-44.3%)
-$3.63B(+6.7%)
Dec 1994
-$3.40B(+1488.3%)
-$1.58B(+87.8%)
-$3.40B(+404.3%)
Sep 1994
-
-$839.60M(+149.7%)
-$674.60M(-27.9%)
Jun 1994
-
-$336.20M(-48.3%)
-$936.10M(+66.1%)
Mar 1994
-
-$649.70M(-156.5%)
-$563.60M(+163.1%)
Dec 1993
-$214.20M(-84.2%)
$1.15B(-204.5%)
-$214.20M(-89.6%)
Sep 1993
-
-$1.10B(-3133.3%)
-$2.06B(+86.4%)
Jun 1993
-
$36.30M(-112.1%)
-$1.11B(-15.3%)
Mar 1993
-
-$300.30M(-56.9%)
-$1.31B(-3.7%)
Dec 1992
-$1.36B(+19.1%)
-$696.20M(+377.8%)
-$1.36B(+15.1%)
Sep 1992
-
-$145.70M(-10.6%)
-$1.18B(-2.7%)
Jun 1992
-
-$162.90M(-53.5%)
-$1.21B(+2.8%)
Mar 1992
-
-$350.50M(-32.4%)
-$1.18B(+3.5%)
Dec 1991
-$1.14B(+19.3%)
-$518.60M(+190.9%)
-$1.14B(+28.9%)
Sep 1991
-
-$178.30M(+37.0%)
-$882.60M(-10.6%)
Jun 1991
-
-$130.10M(-58.2%)
-$987.50M(+3.6%)
Mar 1991
-
-$311.10M(+18.2%)
-$953.60M(-0.0%)
Dec 1990
-$953.70M(-0.2%)
-$263.10M(-7.1%)
-$953.70M(+38.1%)
Sep 1990
-
-$283.20M(+194.4%)
-$690.60M(+69.5%)
Jun 1990
-
-$96.20M(-69.1%)
-$407.40M(+30.9%)
Mar 1990
-
-$311.20M
-$311.20M
Dec 1989
-$955.40M
-
-

FAQ

  • What is Merck & Co annual cash flow from financing activities?
  • What is the all time high annual CFF for Merck & Co?
  • What is Merck & Co annual CFF year-on-year change?
  • What is Merck & Co quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Merck & Co?
  • What is Merck & Co quarterly CFF year-on-year change?
  • What is Merck & Co TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Merck & Co?
  • What is Merck & Co TTM CFF year-on-year change?

What is Merck & Co annual cash flow from financing activities?

The current annual CFF of MRK is -$7.03B

What is the all time high annual CFF for Merck & Co?

Merck & Co all-time high annual cash flow from financing activities is $2.59B

What is Merck & Co annual CFF year-on-year change?

Over the past year, MRK annual cash flow from financing activities has changed by -$2.22B (-46.20%)

What is Merck & Co quarterly cash flow from financing activities?

The current quarterly CFF of MRK is -$5.75B

What is the all time high quarterly CFF for Merck & Co?

Merck & Co all-time high quarterly cash flow from financing activities is $5.21B

What is Merck & Co quarterly CFF year-on-year change?

Over the past year, MRK quarterly cash flow from financing activities has changed by -$2.94B (-104.51%)

What is Merck & Co TTM cash flow from financing activities?

The current TTM CFF of MRK is -$9.97B

What is the all time high TTM CFF for Merck & Co?

Merck & Co all-time high TTM cash flow from financing activities is $2.59B

What is Merck & Co TTM CFF year-on-year change?

Over the past year, MRK TTM cash flow from financing activities has changed by -$4.40B (-79.05%)
On this page